Stock listing

Immuron Limited

Selected listing: IMC · ASX · AUD · AU

Immuron Limited (ASX:IMC), Health Technology. Latest release Sep 24, 2026: Immuron : Annual Report for Fiscal Year Ending June 30, 2026 (Form 20-F).

IMC:ASXAUDAUUpdated October 2, 2026

Ticker: ASX:IMC
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: ASX
Currency: AUD

About Immuron Limited

Immuron Limited is a public company traded on the Australian market under the ticker IMC. Immuron focuses on developing therapies for various health conditions, leveraging its proprietary technology and research.

Latest news from Immuron Limited

Immuron : Annual Report for Fiscal Year Ending June 30, 2026 (Form 20-F)

September 24, 2026

Immuron to launch PROIBS® in the United States

September 4, 2026

PROIBS US Distribution Agreement

September 3, 2026

Immuron Reports FY26 Preliminary Results

August 28, 2026

FY26 Results Presentation

August 27, 2026

All Immuron Limited news →

Research Immuron Limited

Immuron Limited company profile

View the public company page for Immuron Limited on 6ix.

Immuron Limited news

Read company news and market updates connected to Immuron Limited.

Immuron Limited investor events

Find investor webinars, events, and replay context for Immuron Limited.